Advanced search×

Hematology/Oncology Clinics of North America

Print ISSN
Electronic ISSN
Impact factor
Usage rank
Article count
Free count
Free percentage
PDFs via platforms
Sciencedirect and Mdconsult from 1996

  1. Warm autoimmune hemolytic anemia

    Hematology/Oncology Clinics of North America (2008)

    Warm autoimmune hemolytic anemia (AIHA) is defined as the destruction of circulating red blood cells (RBCs) in the setting of anti-RBC autoantibodies that optimally react at 37oC. The pathophysiology of disease involves phagocytosis of autoantibody-coated RBCs in the spleen and complement-...
  2. Paroxysmal Cold Hemoglobinuria

    Hematology/Oncology Clinics of North America (1982)

    Paroxysmal Cold Hemoglobinuria is a rare cause of autoimmune hemolytic anemia predominantly seen as an acute form in young children after viral illnesses and in a chronic form in some hematological malignancies and tertiary syphilis. It is a complement medicated intravascular hemolytic ane...
  3. Anemia of inflammation.

    Hematology/Oncology Clinics of North America 28(4):671 (2014) PMID 25064707 PMCID PMC4115203

    Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. It is diagnosed when serum iron concentrations are low despite adequate iron stores, as evidenced by serum ferritin that is...
  4. Melanoma adjuvant therapy.

    Hematology/Oncology Clinics of North America 28(3):471 (2014) PMID 24880942

    Adjuvant therapy targets melanoma micrometastases in patients with surgically resected disease that carry a high risk of death from melanoma recurrence. In this setting, adjuvant therapy provides the greatest opportunity for cure before progression into advanced inoperable stages. In randomized clin...
  5. Targeted therapies for cutaneous melanoma.

    Hematology/Oncology Clinics of North America 28(3):491 (2014) PMID 24880943

    Melanoma is resistant to cytotoxic therapy, and treatment options for advanced disease have been limited historically. However, improved understanding of melanoma driver mutations, particularly those involving the mitogen-activated protein kinase pathway, has led to the development of targeted thera...
  6. Induction therapy for advanced-stage Hodgkin lymphoma: late intensification (ABVD chemotherapy followed by high-dose chemotherapy and autolo...

    Hematology/Oncology Clinics of North America 28(1):75 (2014) PMID 24287069

    The goal of therapy for patients with advanced-stage Hodgkin lymphoma is to ensure that as many patients as possible are healthy and free of disease decades after completing treatment. To achieve this, the treating physician needs to select the most effective therapeutic regimen, but also needs to c...
  7. Testing platelet function.

    Hematology/Oncology Clinics of North America 27(3):411 (2013) PMID 23714306

    Platelet function tests have been traditionally used to aid in the diagnosis and management of patients with bleeding problems. Given the role of platelets in atherothrombosis, several dedicated platelet function instruments are now available that are simple to use and can be used as point-of-care a...
  8. Synovial cell sarcoma of the larynx.

    Hematology/Oncology Clinics of North America 26(6):1209 (2012) PMID 23116577

    Synovial cell sarcoma represents a rare group of cancers, particularly in the head and neck region, that typically affects young individuals and has a male preponderance. Prognosis varies with patient age, site and size of the malignancy, degree of necrosis, high level of mitotic activity, and neuro...
  9. Current treatment of anal squamous cell carcinoma.

    Hematology/Oncology Clinics of North America 26(6):1315 (2012) PMID 23116582

    The primary aim of anal cancer treatment is loco-regional control with preservation of anal function. Phase III trials consistently demonstrate radiotherapy with concurrent 5FU and mitomycin (MMC) chemoradiation is the standard of care for anal cancer. Salvage surgery is associated with considerable...
  10. Central nervous system malignancies.

    Hematology/Oncology Clinics of North America 26(4):xiii (2012) PMID 22794292